Progressive Coronary Dilatation Predicts Worse Outcome in Kawasaki Disease

被引:21
作者
Chih, Wan-Ling [1 ,2 ]
Wu, Pei-Yuan [1 ,2 ]
Sun, Li-Chuang [3 ]
Lin, Ming-Tai [1 ,2 ]
Wang, Jou-Kou [1 ,2 ]
Wu, Mei-Hwan [3 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan South Rd, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[3] Cardinal Tien Gen Hosp, Dept Pediat, Taipei, Taiwan
关键词
ARTERY LESIONS; PREVALENCE; ANEURYSMS;
D O I
10.1016/j.jpeds.2015.12.076
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To explore the implication of serial coronary changes on the late coronary outcomes in patients with Kawasaki disease (KD) with coronary aneurysms >= 4 mm. Study design We performed a retrospective review of 78 patients with KD with large coronary aneurysms (19802013, male: 76.9%; 792 patient-years). Progressive coronary dilatation was defined for those with progressive enlargement of coronary arteries in 3 consecutive echocardiograms. Results We studied 27 patients with KD with giant aneurysms (>= 8 mm) and 51 patients with KD with medium aneurysms (4-8 mm). All the giant and 43.1% of medium aneurysms persisted during the study period. For the patients with giant aneurysms, their 10-year freedom from acute myocardial infarction/cardiovascular death and all ischemia was 66% and 52%, respectively. The median intervals for the aneurysm diameters reaching their peak were 3.3 months (giant) and 0.25 months (medium), respectively. In patients with giant aneurysms, the 10-year freedom from ischemia was much lower in those with progressive coronary dilatation (28% vs 59%, P = .021). In patients with medium aneurysms, the probability of 5-year persistence of aneurysm was much greater (67.2% vs 14.8%, P < 10(-3)) in those with progressive coronary dilatation. Male sex and intravenous immunoglobulin therapy were not associated with the late outcomes in the patients with KD who had aneurysms larger than 4 mm. Conclusions In addition to coronary diameters 1 month after the onset of KD, progressive coronary dilatation at 2 or more months after diagnosis may be an indicator of duration, and the severity of vasculitis and adverse dilative remodeling were associated with worse late coronary outcomes.
引用
收藏
页码:78 / +
页数:6
相关论文
共 18 条
  • [1] Gold LI, 1997, AM J PATHOL, V150, P209
  • [2] Epidemiology of Kawasaki Disease: Prevalence from National Database and Future Trends Projection by System Dynamics Modeling
    Huang, San-Kuei
    Lin, Min-Tai
    Chen, Hui-Chi
    Huang, Shin-Chung
    Wu, Mei-Hwan
    [J]. JOURNAL OF PEDIATRICS, 2013, 163 (01) : 126 - U522
  • [3] Kawasaki T, 1967, Arerugi, V16, P178
  • [4] Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy
    Lin, Ming-Tai
    Sun, Li-Chuan
    Wu, En-Ting
    Wang, Jou-Kou
    Lue, Hung-Chi
    Wu, Mei-Hwan
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (06) : 542 - 547
  • [5] Lin MT, 2014, ACTA CARDIOL SIN, V30, P266
  • [6] Elevated levels of high-sensitivity c-reactive protein and serum amyloid-A late after Kawasaki disease - Association between inflammation and late coronary sequelae in Kawasaki disease
    Mitani, Y
    Sawada, H
    Hayakawa, H
    Aoki, K
    Ohashi, H
    Matsumura, M
    Kuroe, K
    Shimpo, H
    Nakano, M
    Komada, Y
    [J]. CIRCULATION, 2005, 111 (01) : 38 - 43
  • [7] REPEATED QUANTITATIVE ANGIOGRAMS IN CORONARY ARTERIAL ANEURYSM IN KAWASAKI DISEASE
    NAKANO, H
    UEDA, K
    SAITO, A
    NOJIMA, K
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (13) : 846 - 851
  • [8] NAOE S, 1991, ACTA PATHOL JAPON, V41, P785
  • [9] Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association
    Newburger, JW
    Takahashi, M
    Gerber, MA
    Gewitz, MH
    Tani, LY
    Burns, JC
    Shulman, ST
    Bolger, AF
    Ferrieri, P
    Baltimore, RS
    Wilson, WR
    Baddour, LM
    Levison, ME
    Pallasch, TJ
    Falace, DA
    Taubert, KA
    [J]. PEDIATRICS, 2004, 114 (06) : 1708 - 1733
  • [10] Guidelines for Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease (JCS 2013) - Digest Version
    Ogawa, Shunichi
    Ayusawa, Mamoru
    Fukazawa, Ryuji
    Hamaoka, Kenji
    Ishii, Masahiro
    Nishigaki, Kazuhiko
    Ogino, Hirotarou
    Saji, Tsutomu
    Kamiyama, Hiroshi
    Ochi, Masami
    Takahashi, Kei
    Tsuda, Etsuko
    Yokoi, Hiroyoshi
    Akasaka, Takashi
    Kitamura, Soichiro
    Nakamura, Yoshikazu
    Nakanishi, Toshio
    Sonobe, Tomoyoshi
    [J]. CIRCULATION JOURNAL, 2014, 78 (10) : 2521 - 2562